β-Amyloid-mediated vasoactivity and vascular endothelial damage
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Deposits of beta-amyloid are apparent in ageing and Alzheimer's disease, but the role of this peptide in neurodegeneration is unclear. The free-radical theory of ageing may also account for Alzheimer-type degeneration and consequently links between free-radical generation and beta-amyloid have been sought. We demonstrate here that beta-amyloid interacts with endothelial cells on blood vessels to produce and excess of superoxide radicals, with attendant alterations in endothelial structure and function. The superoxide radical can scavenge endothelium-derived relaxing factor and produce potent oxidizing agents, which can cause lipid peroxidation and other degenerative changes. The alterations in vascular tone and endothelial damage are prevented by the oxygen-radical-scavenging enzyme superoxide dismutase. These observations suggest a normal vasoactive role for beta-amyloid as well as a mechanism by which beta-amyloid may play a role in vascular abnormalities and neurodegeneration mediated by free radicals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ is a potent vasoconstrictor113,114 and suppresses endothelium-dependent responses, functional hyperemia, and cerebrovascular autoregulation.115–117”
In the citing paper
“As shown by pharmacological studies, these high concentrations of A b may impair local BBB integrity (58-59), which in turn may contaminate brain ISF with blood and/or plasma that possesses A b -degrading activity (48)”
From Clearance of Alzheimer’s amyloid-β1-40 peptide from brain by LDL receptor–related protein-1 at the blood-brain barrier (2000) · cites this paper as [59]
In the citing paper
“Aβ4 constrict isolated cerebral and systemic blood vessels (Niwa et al., 2001; Paris et al., 2003; Thomas et al., 1996)”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Thomas et al., 1996
Citations
Cites
Furchgott, R. F., & Zawadzki, J. V. (1980) · Nature · doi:10.1038/288373a0 · Cited by 12,064
Lipton, S. A., Choi, Y.-B., Pan, Z.-H., Lei, S. Z., Chen, H.-S. V., Sucher, N. J., Loscalzo, J., Singel, D. J., & Stamler, J. S. (1993) · Nature · doi:10.1038/364626a0 · Cited by 2,433
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91209-9 · Cited by 1,693
β-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease
Mattson, M. P., Barger, S. W., Cheng, B., Lieberburg, I., Smith-Swintosky, V. L., & Rydel, R. E. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90009-b · Cited by 518
PGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH.
Kukreja, R. C., Kontos, H. A., Hess, M. L., & Ellis, E. F. (1986) · Circulation Research · doi:10.1161/01.res.59.6.612 · Cited by 487
Bu�e, L., Hof, P. R., Bouras, C., Delacourte, A., Perl, D. P., Morrison, J. H., & Fillit, H. M. (1994) · Acta Neuropathologica · doi:10.1007/bf00294173 · Cited by 334
Scholz, W. (1938) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02890989 · Cited by 180
Soluble β-Amyloid Induction of Alzheimer's Phenotype for Human Fibroblast K + Channels
Etcheberrigaray, R., Ito, E., Kim, C. S., & Alkon, D. L. (1994) · Science · doi:10.1126/science.8146663 · Cited by 167
Untangling the pathophysio-chemistry of β-amyloid
Mattson, M. P. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb1195-926 · Cited by 41
Research works printed but not linked: 2
- Davignon, J., Gregg, R. & Sing, C. Atherosclerosis 8, 1–21 (1988).
- Tomimoto, H., Nakimura, S., Wakita, H., Kimura, J. & Akiguchi, I. J. Cereb. Blood Flow Metab. 14, 563–573 (1994).
Cited by
Items 501–600 of 710
β-Amyloid-Induced Coronary Artery Vasoactivity and Endothelial Damage
Thomas, T., Sutton, E. T., Hellermann, A., & Price, J. M. (1997) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199710000-00017 · Cited by 18
Self-citationWeiner, H. L., Lemere, C. A., Maron, R., Spooner, E. T., Grenfell, T. J., Mori, C., Issazadeh, S., Hancock, W. W., & Selkoe, D. J. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200010)48:4<567::aid-ana3>3.0.co;2-w · Cited by 263
Evidence that glypican is a receptor mediating β-amyloid neurotoxicity in PC12 cells
Schulz, J. G., Megow, D., Reszka, R. C., Villringer, A., Einhäupl, K. M., & Dirnagl, U. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00220.x · Cited by 20
Nassar, B. A., Darvesh, S., Bevin, L. D., Rockwood, K. J., Kirkland, S., O’Neill, B. J., Bata, I. R., Johnstone, D. E., & Title, L. M. (2002) · Clinical Biochemistry · doi:10.1016/s0009-9120(02)00296-5 · Cited by 18
Singh, P. K., Badimon, A., Chen, Z., Strickland, S., & Norris, E. H. (2021) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12504 · Cited by 20
Sasahara, T., Satomura, K., Tada, M., Kakita, A., & Hoshi, M. M. (2021) · iScience · doi:10.1016/j.isci.2021.102936 · Cited by 17
Gökçal, E., Horn, M. J., Becker, J. A., Das, A. S., Schwab, K. M., Biffi, A., Rost, N. S., Rosand, J. M., Viswanathan, A., Polimeni, J. R., et al. (2022) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x221076571 · Cited by 19
NADPH Is an Allosteric Regulator of HSCARG
Dai, X., Li, Y., Meng, G., Yao, S., Zhao, Y., Yu, Q., Zhang, J., Luo, M., & Zheng, X. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.02.049 · Cited by 20
Ielacqua, G. D., Schlegel, F., Füchtemeier, M., Xandry, J., Rudin, M., & Klohs, J. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00241 · Cited by 19
“Additionally, in culture Aβ has been shown to be toxic to endothelial cells (Thomas et al., 1996; Price et al., 2001).”
BackgroundBuckwalter, M. S., Pepper, J., Gaertner, R., Euw, D. V., Lacombe, P. M., & Wyss‐Coray, T. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04801.x · Cited by 19
Waigi, E. W., Pernomian, L., Crockett, A. M., Costa, T. J. D., Townsend, P., Webb, R. C., McQuail, J. A., McCarthy, C. G., Hollis, F., & Wenceslau, C. F. (2024) · GeroScience · doi:10.1007/s11357-024-01213-0 · Cited by 19
“Evidence shows that Aβ peptides enhance the vasoconstriction of rat aortas to PE or endothelin-1 [9, 33, 39].”
BackgroundResultInfluentialAmyloids in Site-Specific Autoimmune Reactions and Inflammatory Responses
Huang, Y., Hong, X., Shen, J. X., Geng, L.-J., Pan, Y.-H., Ling, W., & Zhao, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02980 · Cited by 16
“Such chronic inflammation results in serious disadvantages, such as immune-competent cells deprivation, more APP synthesis, and cellular dysfunction or death (113, 114).”
BackgroundEstrés oxidativo, péptido β-amiloide y enfermedad de Alzheimer
Manzano‐León, N., & Mas‐Oliva, J. (2006) · Gaceta Médica de México · Cited by 23
Vascular Gene Polymorphisms ( EDNRA -231 G>A and APOE HhaI) and Risk for Migraine
Joshi, G. S., Pradhan, S., & Mittal, B. (2011) · DNA and Cell Biology · doi:10.1089/dna.2010.1197 · Cited by 16
“The E4 isoform is known to promote the deposition of amyloid, a protein known to damage endothelial cells by producing superoxide radicals (Thomas et al. , 1996).”
Axon–glial disruption: the link between vascular disease and Alzheimer's disease?
Horsburgh, K. J., Reimer, M. M., Holland, P. R., Chen, G., Scullion, G. A., & Fowler, J. H. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390881 · Cited by 17
Dissociation of ERK and Akt signaling in endothelial cell angiogenic responses to β-amyloid
Magrané, J., Christensen, R. A., Rosen, K. M., Veereshwarayya, V., & Querfurth, H. W. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.12.009 · Cited by 16
Binding of Amyloid Beta-Protein to Intracellular Brain Proteins in Rat and Human
Ray, I., Chauhan, A., Wísniewski, H. M., Węgiel, J., Kim, K. S., & Chauhan, V. P. S. (1998) · Neurochemical Research · doi:10.1023/a:1020744216699 · Cited by 16
Jäkel, L., Biemans, E. A. L. M., Klijn, C. J. M., Kuiperij, H. B., & Verbeek, M. M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01873-x · Cited by 17
Pinder, R. M. (2009) · International Journal of Wine Research · doi:10.2147/ijwr.s4691 · Cited by 16
“…especially plaque formation, does involve oxidative processes, while normal aging has been ascribed to the production of free radicals, 94,95 Table 3 Effects of alcohol which protect against CHD, stroke and dementia 5,79,80,103,105 • Antiatherosclerotic: – Increased levels of…”
THE PRINCE HENRY HOSPITAL DEMENTIA CAREGIVERS? TRAINING PROGRAMME
BRODATY, H., GRESHAM, M., & LUSCOMBE, G. (1997) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199702)12:2<183::aid-gps584>3.0.co;2-j · Cited by 210
Ishikawa, H., Ozawa, H., Saito, T., Takahata, N., & Takemura, H. (1998) · Life Sciences · doi:10.1016/s0024-3205(97)01169-7 · Cited by 17
Progressive mechanical and structural changes in anterior cerebral arteries with Alzheimer’s disease
Liu, X., Halvorsen, S., Blanke, N., Downs, M. J., Stein, T. D., Bigio, I. J., Zaia, J., & Zhang, Y. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01331-5 · Cited by 18
“Evidence has also shown that when Aβ in artery wall interacts with endothelium, oxidative stress increases which further contributes to Aβ increase, neurodegradation, and possible cognitive decline [69, 70].”
BackgroundAlzheimer’s Disease Is Associated with a Low Prevalence of Hypertension
Kuyumcu, M. E., Yeşil, Y., Öztürk, Z. A., Halil, M. G., Ülger, Z., Doğu, B. B., Cankurtaran, M., Çınar, E., & Arıoğul, S. (2012) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000336053 · Cited by 14
Enhanced Aβ1–40 Production in Endothelial Cells Stimulated with Fibrillar Aβ1–42
Rajadas, J., Sun, W., Li, H., Inayathullah, M., Cereghetti, D. M., Tan, A., Coelho, V. D. M., Chrest, F. J., Kusiak, J. W., Smith, W. W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058194 · Cited by 16
Palmer, J. C., Tayler, H. M., Dyer, L., Kehoe, P. G., Paton, J. F. R., & Love, S. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-190630 · Cited by 14
Anwar, M. M., & Mabrouk, A. A. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01202-3 · Cited by 14
Superoxide dismutase activity in the mongolian gerbil brain after acute poisoning with aluminum
Mićić, D. V., Petronijević, N., & Vučetić, S. S. (2003) · Journal of Alzheimer s Disease · doi:10.3233/jad-2003-5107 · Cited by 15
“Both Al [68], and A β protein aggregates [5,21,61] can induce intracellular oxidative stress.”
Plasma β amyloid and impaired CO2-induced cerebral vasomotor reactivity
van Dijk, E. J., Prins, N. D., Albert Hofman, D., van Duijn, C. M., Koudstaal, P. J., & Breteler, M. M. B. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.03.011 · Cited by 14
Anfuso, C. D., Lupo, G., & Alberghina, M. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00560-1 · Cited by 14
Correlations of Plasma Biomarkers and Imaging Characteristics of Cerebral Small Vessel Disease
Kong, Q., Xie, X., Wang, Z., Zhang, Y., Zhou, X., Wu, L., Yu, Z., Huang, H., & Luo, X. (2024) · Brain Sciences · doi:10.3390/brainsci14030269 · Cited by 14
“The plasma A β may enhance endothelium-dependent vasoconstriction and lead to cerebral hypoperfusion, resulting in WMH [65].”
BackgroundHow to measure and model cardiovascular aging
Spray, L., Richardson, G. D., Booth, L. K., Haendeler, J., Altschmied, J., Bromage, D. I., Wallis, S. B., Stellos, K., Tual‐Chalot, S., & Spyridopoulos, I. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf138 · Cited by 14
Gücüyener, D., Yenilmez, Ç., Ayrancı, Ü., Ozdemir, F., Üzüner, N., Özkan, S., Kaptanoğlu, C., & Özdemır, G. (2010) · The Neurologist · doi:10.1097/nrl.0b013e3181a2eace · Cited by 13
Lupo, G., Anfuso, C. D., Assero, G., Strosznajder, R. P., Walski, M., Pluta, R. M., & Alberghina, M. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01749-9 · Cited by 13
Hereditary and sporadic beta-amyloidoses
Fede, G. D., Giaccone, G., & Tagliavini, F. (2013) · Frontiers in bioscience · doi:10.2741/4173 · Cited by 15
Greenberg, S. M. (2004) · Elsevier eBooks · doi:10.1016/b0-44-306600-0/50039-0 · Cited by 17
Smith, C., Stanyer, L., & Betteridge, D. J. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.05.094 · Cited by 13
Fragments of Amyloid β Induce Apoptosis in Vascular Endothelial Cells
Hase, M., Araki, S., & Hayashi, H. (1997) · Endothelium · doi:10.3109/10623329709052587 · Cited by 13
Homocysteine, vitamin B 6 , and vascular disease in patients with AD
Borroni, B., Agosti, C., Panzali, A., Luca, M. D., & Padovani, A. (2002) · Neurology · doi:10.1212/wnl.59.9.1475 · Cited by 13
Stevenson, T. K., Moore, S. J., Murphy, G. G., & Lawrence, D. A. (2021) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0041-1740265 · Cited by 12
Si, M.-L., Long, C., Chen, M.-F., & Lee, T. J.-F. (2010) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02224.x · Cited by 13
“It has been shown that Abs attenuate endothelium-dependent dilation in peripheral and cerebral arteries (Thomas et al., 1996, 1997, Crawford et al. 1998, Price et al. 2001, Niwa et al. 2001), and potentiate vasoconstriction induced by endothelin and thomboxane (Iadecola et al. 1999, Niwa et al.…”
BackgroundTaheri, S., Yu, J., Zhu, H., & Kindy, M. S. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160331 · Cited by 13
Cordonnier, C., & Leys, D. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544897.062 · Cited by 12
Khodja, E. A. T., Khabtane, A. E. H., Arhab, R., Benouchenne, D., Bensaad, M. S., Bensouıcı, C., & Erenler, R. (2023) · PubMed Central · doi:10.19852/j.cnki.jtcm.20230105.003 · Cited by 11
Wine consumption, cognitive function and dementias – A relationship?
Stockley, C. S. (2015) · Nutrition and Aging · doi:10.3233/nua-150055 · Cited by 11
“[101] Thomas T, Thomas G, McLendon C, Sutton T, Mullan M.”
BackgroundAboelnour, A., Kam, J. H., Elnasharty, M., Sayed-Ahmed, A., & Jeffery, G. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2016.05.015 · Cited by 11
Cantara, S., Ziche, M., & Donnini, S. (2005) · PubMed · Cited by 11
Tau reduction in aged mice does not impact Microangiopathy
Bennett, R. E., Hu, M., Fernandes, A. R., Pérez-Rando, M., Robbins, A. B., Kamath, T. V., Dujardin, S., & Hyman, B. T. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01014-4 · Cited by 12
WIRTH, K. J., Fink, E., Rudolphi, K. A., Heitsch, H., Deutschländer, N., & Wiemer, G. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00576-2 · Cited by 11
Stanyer, L., Betteridge, D. J., & Smith, C. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2003.11.005 · Cited by 14
Simvastatin, Its Antimicrobial Activity and Its Prevention of Alzheimer’s Disease
Dhakal, S., & Macreadie, I. G. (2024) · Microorganisms · doi:10.3390/microorganisms12061133 · Cited by 11
“Proteostasis is connected to several eukaryotic fundamental processes that include the immune system, energy metabolism, vesicle mediated trafficking, the recycling of the cellular materials, synaptic functions, lipid metabolism, stress response, and others.”
BackgroundMoharir, S. C., Raghawan, A. K., Ramaswamy, R., & Swarup, G. (2022) · The Journal of Biochemistry · doi:10.1093/jb/mvac011 · Cited by 10
Perpetuini, D., Filippini, C., Zito, M., Cardone, D., & Merla, A. (2022) · Bioengineering · doi:10.3390/bioengineering9100492 · Cited by 10
“The senile plaques are mainly constituted of amyloid beta peptide, which is generally associated with cerebrovascular alterations, indicating that vascular damage could be involved in the development of AD and not only in the pathogenesis of vascular dementia [4].”
BackgroundZhao, X., Luan, Y., Zuo, X., Chen, Y.-D., Qin, J., Lv, J., Tan, Y., Lin, M., Zhang, N., Liang, Y., et al. (2016) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2016.04.008 · Cited by 12
Argilés, À. (1996) · Nephrology · doi:10.1111/j.1440-1797.1996.tb00117.x · Cited by 10
Oxidative Stress in Alzheimer’s Disease
Ceballos-Picot, I. (1997) · Neuroscience intelligence unit · doi:10.1007/978-3-662-22516-5_5 · Cited by 10
Ezquerra, M., Ballesta, F., Queralt, R., Aledo, R., Gómez, D., Guitart, M., Egozcue, J., Ascaso, C., & Oliva, R. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00251-1 · Cited by 10
Signalling of galanin and amyloid precursor protein through adenylate cyclase
Mahlapuu, R. (2004) · DSpace repository (University of Tartu) · Cited by 119
Circulating amyloid beta 1‐40 peptide as an associate of renal function decline
Mavraganis, G., Georgiopoulos, G. A., Zervas, G., Aivalioti, E., Delialis, D., Petropoulos, I., Rachiotis, N., Konstantaki, C., Moustou, C., Dimopoulou, M., et al. (2025) · European Journal of Clinical Investigation · doi:10.1111/eci.70006 · Cited by 9
Brain Atrophy, Anti-Smooth Muscle Antibody and Cognitive Impairment: An Association Study
Paroni, G., Lauriola, M., Andrea, F., D’Onofrio, G., Ciccone, F., Paris, F., Cascavilla, L., Urbano, M., Gravina, C., Copetti, M., et al. (2016) · Aging and Disease · doi:10.14336/ad.2015.1124 · Cited by 11
“Then the major pathological role of beta-amyloid in AD may be to induce vascular and BBB function damage [2-4].”
BackgroundMOLECULAR BASIS OF G6PD DEFICIENCY: CURRENT STATUS AND ITS PERSPECTIVE
Dalouei, M. R. N., & Maryam, D. P. (2008) · ACTA MEDICA IRANICA · Cited by 9
Alzheimer's Factors in Ischemic Brain Injury
Pluta, R. M., & Jaboski, M. (2012) · InTech eBooks · doi:10.5772/27205 · Cited by 10
“Due to the fact that ┚-amyloid peptide causes vasoconstriction (Thomas et al., 1996; Niwa et al., 2000) and endothelium damage (Thomas et al., 1996), a role for ┚-amyloid peptide in vasoconstriction and blood–brain barrier pathology has been proved.”
BackgroundStochastic Simulations of the Cytochrome P450 Catalytic Cycle
Wang, Y., Li, Y., & Wang, B. (2007) · The Journal of Physical Chemistry B · doi:10.1021/jp071222n · Cited by 9
Osborn, K. E., Alverio, J., Dumitrescu, L. C., Pechman, K. R., Initiative, A. D. N., Gifford, K. A., Hohman, T. J., Blennow, K., Zetterberg, H., & Jefferson, A. L. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190077 · Cited by 10
Yu, Y., Zhang, N., Xiang, B., Ding, N., Liu, J., Huang, J., Zhao, M., Zhao, Y., Wang, Y., & Ma, Z. (2023) · Neurophotonics · doi:10.1117/1.nph.10.1.015005 · Cited by 10
“However, this constriction may be transient.(73) Interestingly, when AD transgenic mice (APP23) were monitored for 20 months, it showed an increase in mean vessel diameter and vessel size index, despite a slight constriction that occurred at 14 months.”
BackgroundAmyloid-like substance in mice and human oocytes and embryos
Pimentel, R. N., Navarro, P. A., Wang, F., Robinson, L. G., Cammer, M., Liang, F., Kramer, Y. G., & Keefe, D. L. (2019) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-019-01530-w · Cited by 9
Sepehrband, F., Barisano, G., Sheikh‐Bahaei, N., Choupan, J., Cabeen, R. P., Crawford, M. S., Mack, W. J., Chui, H. C., Ringman, J. M., Toga, A. W., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.045605 · Cited by 10
Menge, T., von Büdingen, H. ‐., Zamvil, S. S., Hartung, H., Kieseier, B. C., & Stüve, O. (2004) · Der Nervenarzt · doi:10.1007/s00115-004-1806-4 · Cited by 9
β‐amyloid Peptides and Enhancement of Vasoconstriction by Endothelin‐1
Crawford, F., Suo, Z., Fang, C., & MULLAN, M. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48504.x · Cited by 9
Self-citationNO Answer to Alzheimer's Disease?
Chu, Y., & Heistad, D. D. (2010) · Circulation Research · doi:10.1161/circresaha.110.234450 · Cited by 9
“They also inhibited soluble guanylyl cyclase (sGC) with 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1one (ODQ) and increased cGMP with sildenafil.”
BackgroundModelling cerebrovascular pathology and the spread of amyloid beta in Alzheimer’s disease
Ahern, A., Thompson, T., Oliveri, H., Lorthois, S., & Goriely, A. (2025) · Proceedings of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rspa.2024.0548 · Cited by 9
Babušíková, E., Evinová, A., Hatok, J., Dobrota, D., & Jurecekov, J. (2013) · InTech eBooks · doi:10.5772/54619 · Cited by 11
Warchoł-Celińska, E., Styczyńska, M., Prejbisz, A., Przybyłowska, K., Chodakowska-Żebrowska, M., Kurjata, P., Piotrowski, W., Polakowska, M., Kabat, M., Zdrojewski, T. R., et al. (2015) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2015.07.002 · Cited by 8
Choi, B., Seo, J.-H., Back, D. B., Han, J., Choi, D., Kwon, K. J., Shin, C. Y., Lee, J., & Kim, H. Y. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.02.012 · Cited by 8
Hatip, F. F. B., & Hatip‐Al‐Khatib, I. (2013) · Life Sciences · doi:10.1016/j.lfs.2012.12.004 · Cited by 8
Inverse correlation between Alzheimer’s disease and cancer from the perspective of hypoxia
Su, Z., Zhang, G., Li, X., & Zhang, H. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.07.002 · Cited by 7
Peripheral post-ischemic vascular repair is impaired in a murine model of Alzheimer’s disease
Merkulova‐Rainon, T., Mantsounga, C., Broquères-You, D., Pinto, C., Vilar, J., Cifuentes, D., Bonnin, P., Kubis, N., Henrion, D., Silvestre, J., et al. (2018) · Angiogenesis · doi:10.1007/s10456-018-9608-7 · Cited by 8
Genetic abnormalities of the endothelium
BUTANY, J. W., Verma, S., Leask, R. L., Mohsen, B., & Asa, S. L. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10240 · Cited by 7
Smith, C., Stanyer, L., Betteridge, D. J., & Cooper, M. B. (2007) · Clinical Science · doi:10.1042/cs20070082 · Cited by 7
Individuality in Early Eukaryotes and the Consequences for Matazoan Development
Blackstone, N. W. (1998) · Progress in molecular and subcellular biology · doi:10.1007/978-3-642-48745-3_2 · Cited by 8
Cholinergic Neurotransmission, Amyloid-β Peptide and the Pathogenesis of Alzheimer's Disease
Liu, L. (2003) · Cited by 21
A Vascular Connection to Alzheimer's Disease
Rhodin, J. A. G., & Thomas, T. (2001) · Microcirculation · doi:10.1111/j.1549-8719.2001.tb00170.x · Cited by 7
Self-citationYu, J., Zhu, H., Kindy, M. S., & Taheri, S. (2023) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2023.100161 · Cited by 7
Korpela, S., Sundblom, J., Zetterberg, H., Constantinescu, R., Svenningsson, P., Paucar, M., & Niemelä, V. (2024) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2024.122979 · Cited by 6
“A β 42 is considered to be the most pathogenic form of A β (21) and its aggregation leads to neuronal dysfunction mediated by excitotoxicity, neuroinflammation (22,23) and cerebral hypoperfusion (24).”
BackgroundKim, G. H., Kim, B. R., Yoon, H., & Jeong, J. H. (2024) · Scientific Reports · doi:10.1038/s41598-024-68916-4 · Cited by 6
“Additionally, Aβ is known to narrow cerebral arteries 22 .”
BackgroundZinc and Alzheimer's Disease: An Update
Cuajungco, M. P., Lees, G. J., Kydd, R. R., Tanzi, R. E., & Bush, A. I. (1999) · Nutritional Neuroscience · doi:10.1080/1028415x.1999.11747277 · Cited by 7
Xu, S., Liu, Y., Wáng, Q., Liu, F., Xu, F., & Liu, Y. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1150432 · Cited by 7
Metabolic Syndrome and Dementia
Lee, A. Y. (2011) · Journal of the Korean Neurological Association · Cited by 7
Zhang, J., Wu, J., Zeng, W., Zhao, Y., & Zu, H. (2015) · PubMed · Cited by 6
CBF regulation in hypertension and Alzheimer’s disease
Yazdani, N., Kindy, M. S., & Taheri, S. (2020) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2020.1764014 · Cited by 7
Chapter 2. Alzheimer's Disease: Recent Advances on the Amyloid Hypothesis
John, V., Latimer, L. H., Tung, J. S., & Dappen, M. S. (1997) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)61460-8 · Cited by 7
Salsolinol, an endogenous neurotoxin, enhances platelet aggregation and thrombus formation
Lim, K., Noh, J.-Y., Chung, S.-M., Kim, K., Hong, S., Shin, S., on, J.-H., Bae, O.-N., Kim, Y.-D., & Chung, J. (2008) · Thrombosis and Haemostasis · doi:10.1160/th07-08-0529 · Cited by 6
Said, S. I., RAZA, S., & Berisha, H. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb11240.x · Cited by 6
Apolipoprotein E ε4 allele has an impact on vascular reactivity in Alzheimer's disease
Algotsson, A., Nordberg, A. K., & Winblad, B. G. (2000) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(00)00082-0 · Cited by 6
No Evidence of Endothelial Dysfunction in Patients with Alzheimer’s Disease
McGleenon, B. M., Passmore, A. P., McAuley, D. F., & Johnston, G. (2000) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017237 · Cited by 6
Spies, P. E., Verbeek, M. M., Sjögren, M. J. C., de Leeuw, F., & Claassen, J. A. H. R. (2014) · Current Alzheimer Research · doi:10.2174/1567205010666131120101352 · Cited by 8
Potential therapeutic targets for Alzheimer’s disease
McKeon‐O'Malley, C., Saunders, A. J., Bush, A. I., & Tanzi, R. E. (1998) · Emerging Therapeutic Targets · doi:10.1517/14728222.2.2.157 · Cited by 8
Heikkinen, T. (2006) · Cited by 11
Hossain, M. K., & Chae, H. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105905 · Cited by 5
Blocking α1 Adrenergic Receptor as a Novel Target for Treating Alzheimer’s Disease
Pan, X., Lei, Z., Chen, J., Jia, C., Deng, J., Liu, Y., Luo, X., Wang, L., Zi, D., Wang, Z., et al. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00411 · Cited by 7
The role and mechanism of dapagliflozin in Alzheimer disease: A review
Chen, P., Liang, L., Dai, Y., & Hui, S. (2024) · Medicine · doi:10.1097/md.0000000000039687 · Cited by 7
“[77,78] Thomas et al [79] demonstrated that A β induces endothelial dysfunction and damage in rat aorta through the production of ROS.”
Background
Metadata
- Authors
- Thomas, T., Thomas, G., McLendon, C., Sutton, T., & Mullan, M.
- Affiliations
- University of South Florida (US)
- Venue
- Nature
- Published
- 1996-03
- Volume
- 380
- Issue
- 6570
- Pages
- 168-171
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1990427131
- Cited by
- 703
- References
- 12
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 18 · 2023: 22 · 2022: 9 · 2021: 15 · 2020: 24 · 2019: 19 · 2018: 5 · 2017: 12 · 2016: 22 · 2015: 26 · 2014: 16 · 2013: 26 · 2012: 13
- FWCI
- 26.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- amyloid-beta, Alzheimer's disease, vascular endothelial cells, superoxide, free radicals, superoxide dismutase, endothelium-derived relaxing factor, lipid peroxidation, vascular tone, neurodegeneration, aging, oxidative stress
- MeSH terms
- Acetylcholine, Alzheimer Disease, Animals, Aorta, Blood Vessels, Endothelium, Vascular, Nerve Degeneration, Phenylephrine, Superoxides, Vasoconstriction, Vasoconstrictor Agents, Vasodilator Agents, Amyloid beta-Peptides, Rats, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.